Evidence map›Paper›PMID 33355907›Full record

Observational studyAdvances in therapy2021

Asthma and Chronic Obstructive Pulmonary Disease Overlap According to the Japanese Respiratory Society Diagnostic Criteria: The Prospective, Observational ACO Japan Cohort Study.

Shu Hashimoto, Ryoko Sorimachi, Tatsunori Jinnai, Masakazu Ichinose

Erratum issued Registry-linked trialAbstract readMulticenter StudyObservational Study
In one paragraph

Observational study in Advances in therapy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to trial NCT03577795 (A Prospective Cohort Study of Asthma and COPD Overlap in Japanese COPD Patients Using the Diagnostic Criteria of The Japanese Respiratory Society), which is not on this map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03577795 completednot on this map

A Prospective Cohort Study of Asthma and COPD Overlap in Japanese COPD Patients Using the Diagnostic Criteria of The Japanese Respiratory Society

Typeobservational_patient_registrySponsorAstraZenecaRan2018 to 2021Enrolled710ConditionsPulmonary Disease, Chronic Obstructive
3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Sputum microbiota and inflammatory subtypes in asthma, COPD, and its overlap.The journal of allergy and clinical immunology. Global · 2024
    Article
  8. Underdiagnosis of COPD: The Japan COPD Real-World Data Epidemiological (CORE) Study.International journal of chronic obstructive pulmonary disease · 2024
    Article
  9. Article
  10. Review
  11. Observational
  12. Observational
  13. Observational
  14. Article
  15. Narrative review of current COPD status in Japan.Journal of thoracic disease · 2021
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Shu HashimotoNihon University, Itabashi-ku, Tokyo, Japan. hashimoto.shu@nihon-u.ac.jp.ORCID http://orcid.org/0000-0002-7173-8796
Ryoko SorimachiMedical Department, AstraZeneca K.K., Kita-ku, Osaka, Japan.
Tatsunori JinnaiMedical Department, AstraZeneca K.K., Kita-ku, Osaka, Japan.
Masakazu IchinoseAcademic Center of Osaki Citizen Hospital, Miyagi, Japan. ichinose@h-osaki.jp.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionPatients with asthma-chronic obstructive pulmonary disease (COPD) overlap (ACO) present with chronic respiratory symptoms with features of both asthma and COPD. New ACO diagnostic criteria (2018) were suggested by the Japanese Respiratory Society (JRS). This prospective, multicenter, observational cohort study was conducted to investigate the proportion of patients who meet the JRS ACO diagnostic criteria among COPD patients in clinical practice.

methodsThis 2-year ongoing study enrolled consecutive outpatients aged ≥ 40 years with COPD who visited one of 27 Japanese centers at which the medical examinations/tests required for ACO diagnosis were routinely conducted. At registration, the proportion of ACO or non-ACO patients was determined using the JRS diagnostic criteria, and the characteristics of the two groups were compared using analysis of variance and chi-square test.

resultsOf 708 COPD patients analyzed at registration, 396 (55.9%) had the data necessary for ACO diagnosis to be conducted, and 312 (44.1%) were lacking these data. Of the 396 patients who had the data necessary for ACO diagnosis, 101 (25.5%) met the diagnostic criteria for ACO, and 295 (74.5%) did not (non-ACO patients). ACO patients were younger, had a greater rate of asthma based on a physician's diagnosis, and used more medications, including inhaled corticosteroids (p < 0.05), compared with non-ACO patients.

conclusionsWe have determined the proportion of patients with the data necessary to diagnose ACO using the JRS criteria, and the proportion of these who met the ACO criteria among the COPD population at the time of registration. Patients, including those lacking necessary examination/test data at registration, will continue to undergo follow-up to explore changes in their testing and ACO diagnostic status over time. Analyses of study data over 2 years will provide relevant information on the ACO symptoms, clinical course, and real-world treatment patterns.

trial registrationClinicalTrials.gov identifier, NCT03577795.

Indexed as

AsthmaPulmonary Disease, Chronic ObstructiveAgedCohort StudiesHumansJapanProspective StudiesACOAirflow limitationAsthmaClinical courseCOPDDiagnostic criteriaJapanObservational studyRespiratory symptomsTreatment outcome

Identifiers

PMID33355907
PMCPMC7889677

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.